{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T04:22:47Z","timestamp":1769833367879,"version":"3.49.0"},"reference-count":12,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.clinre.2024.102435","type":"journal-article","created":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T15:46:13Z","timestamp":1722267973000},"page":"102435","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Giant cell hepatitis associated with autoimmune hemolytic anemia: More evidence for B-cell depletion therapy for a rare immune mediated disease of infancy"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8201-2416","authenticated-orcid":false,"given":"Giuseppe","family":"Maggiore","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Sciveres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinre.2024.102435_bib0001","doi-asserted-by":"crossref","first-page":"25","DOI":"10.21037\/tgh.2020.03.10","article-title":"Giant cell hepatitis associated with autoimmune hemolytic anemia: an update","volume":"6","author":"Nastasio","year":"2021","journal-title":"Transl Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2024.102435_bib0002","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/S0022-3476(81)80388-5","article-title":"Severe giant cell hepatitis with autoimmune hemolytic anemia in early 15. childhood","volume":"99","author":"Bernard","year":"1981","journal-title":"J Pediatr"},{"key":"10.1016\/j.clinre.2024.102435_bib0003","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1097\/MPG.0000000000001910","article-title":"Should giant cell hepatitis with autoimmune hemolytic anemia be considered a pediatric autoimmune liver disease?","volume":"66","author":"Nastasio","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.clinre.2024.102435_bib0004","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jpeds.2010.12.050","article-title":"Giant cell hepatitis with autoimmune hemolytic anemia in early 16. childhood: long-term outcome in 16 children","volume":"159","author":"Maggiore","year":"2011","journal-title":"J Pediatr"},{"key":"10.1016\/j.clinre.2024.102435_bib0005","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1136\/adc.77.3.249","article-title":"Liver transplant for giant cell hepatitis with autoimmune haemolytic anaemia","volume":"77","author":"Melendez","year":"1997","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.clinre.2024.102435_bib0006","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.clinre.2015.03.009","article-title":"Efficacy of intravenous immunoglobulin therapy in giant cell hepatitis with autoimmune hemolytic anemia: a multicenter study","volume":"40","author":"Marsalli","year":"2016","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.clinre.2024.102435_bib0007","first-page":"837","article-title":"Autoimmune hemolytic anemia with giant cell hepatitis: case report and review of the literature","volume":"26","author":"Gorelik","year":"2004","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.clinre.2024.102435_bib0008","doi-asserted-by":"crossref","first-page":"e1206","DOI":"10.1542\/peds.2014-0032","article-title":"Anti-CD20 treatment for giant cell hepatitis with autoimmune hemolytic anemia","volume":"134","author":"Paganelli","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.clinre.2024.102435_bib0009","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.clinre.2019.03.010","article-title":"B-cell depletion induces prolonged remission in patients with giant cell hepatitis and autoimmune hemolytic anemia","volume":"44","author":"Matarazzo","year":"2020","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.clinre.2024.102435_bib0010","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/MPG.0b013e318033169f","article-title":"Alemtuzumab for giant cell hepatitis with autoimmune hemolytic anemia","volume":"45","author":"Rovelli","year":"2007","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.clinre.2024.102435_bib0011","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/MPG.0b013e3182a98dbe","article-title":"Humoral immune mechanism of liver injury in giant cell hepatitis with autoimmune hemolytic anemia","volume":"58","author":"Whitington","year":"2014","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"7","key":"10.1016\/j.clinre.2024.102435_bib0012","article-title":"Efficacy of rituximab-containing regimens used as first-line and rescue therapy for giant cell hepatitis with autoimmune hemolytic anemia: a retrospective study","volume":"48","author":"Xue-Yuan","year":"2024","journal-title":"Clin Res Hepatol Gastroenterol"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740124001566?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740124001566?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T07:29:36Z","timestamp":1727767776000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740124001566"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":12,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S2210740124001566"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2024.102435","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Giant cell hepatitis associated with autoimmune hemolytic anemia: More evidence for B-cell depletion therapy for a rare immune mediated disease of infancy","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2024.102435","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102435"}}